UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026159
Receipt number R000030060
Scientific Title A pilot study for hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donor for non-malignant diseases (Halo-NM)
Date of disclosure of the study information 2017/03/01
Last modified on 2020/12/13 09:10:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A pilot study for hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donor for non-malignant diseases (Halo-NM)

Acronym

A pilot study for SCT from HLA-mismatched donor for non-malignant diseases

Scientific Title

A pilot study for hematopoietic stem cell transplantation with post-transplantation cyclophosphamide and anti-thymoglobulin from HLA-mismatched related donor for non-malignant diseases (Halo-NM)

Scientific Title:Acronym

A pilot study for SCT from HLA-mismatched donor for non-malignant diseases

Region

Japan


Condition

Condition

Non-malignant diseases (bone marrow failure, immunodeficiency, inborn errors of metabolism)

Classification by specialty

Hematology and clinical oncology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and safety of hematopoietic stem cell transplantation from HLA-mismatched related donor with post-transplant cyclophosphamide and anti-thymocyte globulin.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of events (acute GVHD grade III or more, graft failure, death) by day 30

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Conditioning regimen with anti-thymocyte globulin.
Stem cell transplantation at day 0.
Cyclophosphamide at day 3 and 4.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

25 years-old >

Gender

Male and Female

Key inclusion criteria

1) Diagnosed as bone marrow failure, immunodeficiency, or inborn errors of metabolism
2) Fanconi anemia is excluded for bone marrow failure.
3) No HLA 5/6 (A, B, DR) or more matched related donor
4) No HLA 6/6 (A, B, DR) matched unrelated donor
5) Transplantation from 2- or more-antigen mismatched related donor
6) Age at transplantation <25 years
7) ECOG Performance status: 0-2
8) Sufficient organ function, as follows;
a. T-Bil <= 1.5 mg/dl
b. Serum creatinine <= 0.8 mg/dl (age <5y), <= 1.2 mg/dl (age 5-9y), <= 1.5 mg/dl (10y or older)
c. Ejection fraction 45% or better, and QTfc <0.45 sec
9) Obtained informed consent from a guardian of the patient

Key exclusion criteria

1. Effusion with grade 2 or worse at CTCAE ver 4.0
2. Uncontrolled infection
3. Severe psychological disorders
4. Pregnant or suspected pregnancy
5. Not eligible for this study at the discretion of the investigator.

Target sample size

9


Research contact person

Name of lead principal investigator

1st name Motohiro
Middle name
Last name Kato

Organization

National Center for Child Health and Development

Division name

Children's Cancer Center

Zip code

157-8535

Address

2-10-1, Okura, Setagaya, Tokyo

TEL

03-3416-0181

Email

kato-mt@ncchd.go.jp


Public contact

Name of contact person

1st name Motohiro
Middle name
Last name Kato

Organization

National Center for Child Health and Development

Division name

Children's Cancer Center

Zip code

157-8535

Address

2-10-1, Okura, Setagaya, Tokyo

TEL

03-3416-0181

Homepage URL


Email

kato-mt@ncchd.go.jp


Sponsor or person

Institute

National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

National Center for Child Health and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Child Health and Development

Address

2-10-1, Okura, Setagaya, Tokyo JAPAN

Tel

03-3416-0181

Email

rinri@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立成育医療研究センター(東京都)、東京医科歯科大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2017 Year 02 Month 28 Day

Date of IRB

2017 Year 02 Month 27 Day

Anticipated trial start date

2017 Year 03 Month 01 Day

Last follow-up date

2020 Year 07 Month 23 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 16 Day

Last modified on

2020 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030060


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name